Who Paid My Doc
Margaret Collins
Pediatric Pathology Cincinnati, OH Medical Doctor
NPI 1942301817 CMS profile 504118
3333 Burnet Ave, Ml 1010, Cincinnati, OH 45229
General payments
$133,127
Research payments
$80,738
Ownership & investment interest
$0
Research they led as principal investigator
$2,550
Through program year 2025, Margaret Collins of Cincinnati, OH is reported in the CMS Open Payments database as having received $133,127 across 139 general payments and $80,738 in research payments paid to them. Separately, studies naming them as principal investigator received $2,550 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $32,515 | 39 | |
| 2025 | Research | $16,695 | 19 | |
| 2024 | General | $5,767 | 18 | |
| 2024 | Research | $13,005 | 18 | |
| 2023 | General | $74,807 | 45 | |
| 2023 | Research | $11,628 | 18 | |
| 2022 | General | $1,098 | 1 | |
| 2022 | Research | $7,356 | 17 | |
| 2021 | General | $7,550 | 2 | |
| 2021 | Research | $3,934 | 13 | |
| 2020 | General | $7,422 | 11 | |
| 2020 | Research | $21,278 | 19 | |
| 2019 | General | $3,968 | 23 | |
| 2019 | Research | $6,843 | 8 |
Beside peers
- Margaret Collins
- Pediatric Pathology median
- Middle half of Pediatric Pathology
- National median
In program year 2025, general payments to Margaret Collins were reported at $32,515. Among 29 Pediatric Pathology profiles paid that year, the median was $29 and the middle half received between $16 and $85.
Show as a table
| Year | Margaret Collins | Pediatric Pathology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $3,968 | $134 | $82–$526 | $163 |
| 2020 | $7,422 | — | — | $114 |
| 2021 | $7,550 | $38 | $17–$1,529 | $132 |
| 2022 | $1,098 | $64 | $23–$200 | $149 |
| 2023 | $74,807 | — | — | $160 |
| 2024 | $5,767 | $69 | $18–$219 | $164 |
| 2025 | $32,515 | $29 | $16–$85 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
251 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Pathology in Ohio
Miriam Conces
Pediatric Pathology · Columbus, OH
Christopher Pierson
Pediatric Pathology · Columbus, OH
Michelle Smith
Pediatric Pathology · Springboro, OH
Jennifer Picarsic
Pediatric Pathology · Cincinnati, OH
Sarangarajan Ranganathan
Pediatric Pathology · Cincinnati, OH
Samir Kahwash
Pediatric Pathology · Columbus, OH
Related records
Pediatric Pathology in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Pathology
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.